Bio-Genex Laboratories Inc BGNX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / —
- Market Cap
- —
- Volume/Avg
- 951 / 802
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bio-Genex Laboratories Inc is a United States-based company engaged in the business of designing, developing, and commercializing molecular pathology systems for cancer diagnosis, prognosis, precession medicine, and life science research. Its products include Xmatrx systems, i6000 systems, i500 Plus, EZ-Retriever, IHC primary antibodies, microRNA probes, special stains, and IHC/ISH detection kits, among others. The product areas in which the company focuses are multiple fully automated molecular pathology workstations, Immunohistochemistry, In-situ hybridization, Fluorescence in-situ hybridization, Multiplex stains, In-situ PCR, and MicroRNA and HPV probe systems. The organization has a business presence all around the globe.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.biogenex.com
Valuation
Metric
|
BGNX
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
BGNX
|
---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
Metric
|
BGNX
|
---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Diagnostics & Research Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Zydxmvgn | Mwrx | $208.9 Bil | |
DHR
| Danaher Corp | Jsxcknplbs | Jtkbfm | $177.3 Bil | |
IQV
| IQVIA Holdings Inc | Tvtxnnx | Dlslgl | $41.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Jnmsqnfh | Jytpldm | $39.7 Bil | |
A
| Agilent Technologies Inc | Jrcdsgdfl | Xdpx | $39.4 Bil | |
MTD
| Mettler-Toledo International Inc | Mmgxhtqkn | Rvzwx | $25.6 Bil | |
ICLR
| Icon PLC | Dsdxhyvc | Kktnktl | $24.1 Bil | |
ILMN
| Illumina Inc | Fjljdjjs | Hlyjdy | $18.8 Bil | |
WAT
| Waters Corp | Gvwfbmhxh | Dpwst | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Zgwznvkhrx | Svfhp | $16.8 Bil |